We design novel and unconventional therapeutics — from small molecules to engineered nucleic acids — guided by molecular structure, biological insight, and therapeutic intent. Precision and purpose drive every stage of our discovery process.

We explore emerging RNA biology, including RNA–protein interactions, RNA metabolism, and system-level regulation across cancer biology, the gut–brain axis, aging, and the molecular boundary between cellular senescence and immortality.

We engineer therapeutics with defined purpose — adaptable across modalities and tailored for personalization. Our approach enables multi-functional and combinatorial therapies designed to address disease complexity rather than single targets.